FDA NDC Directory · JSON-LD · Markdown
NDC 63323-340 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, FOR SOLUTION
| Labeler / Manufacturer | Fresenius Kabi USA, LLC |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA065441 |
| Dosage form / route | INJECTION, POWDER, FOR SOLUTION · INTRAVENOUS |
| Active ingredients | CEFEPIME HYDROCHLORIDE (2 g/1) |
| Marketing started | 20100830 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).